Cited by 143Treatment of Major DepressionMitochondrial Function and PathologyBipolar Disorder and Treatment

The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Open access
Giménez-Palomo, Anna, Dodd, Seetal, Anmella, Gerard, Carvalho, Andre F., Scaini, Giselli, Quevedo, Joao, Pacchiarotti, Isabella, Vieta, Eduard +1 more·2021·Frontiers in Psychiatry

Abstract

Mitochondria are cellular organelles involved in several biological processes, especially in energy production. Several studies have found a relationship between mitochondrial dysfunction and mood disorders, such as major depressive disorder and bipolar disorder. Impairments in energy production are found in these disorders together with higher levels of oxidative stress. Recently, many agents capable of enhancing antioxidant defenses or mitochondrial functioning have been studied for the treatment of mood disorders as adjuvant therapy to current pharmacological treatments. A better knowledge of mitochondrial physiology and pathophysiology might allow the identification of new therapeutic targets and the development and study of novel effective therapies to treat these specific mitochondrial impairments. This could be especially beneficial for treatment-resistant patients. In this article, we provide a focused narrative review of the currently available evidence supporting the involvement of mitochondrial dysfunction in mood disorders, the effects of current therapies on mitochondrial functions, and novel targeted therapies acting on mitochondrial pathways that might be useful for the treatment of mood disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2021.546801

Cites

379 of 379 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mitochondrial function is widely recognized as a factor in the pathophysiology of several psychiatric disorders, including MDD, and a variety of physical conditions, such as metabolic diseases, cardiovascular diseases, and neurodegenerative disorders.

    “Mitochondrial function is widely recognized as a factor in the pathophysiology of several psychiatric disorders, including MDD216, and a variety of physical conditions, such as metabolic diseases217, cardiovascular diseases218, and neurodegenerative disorders219.”

    From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [216]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

2 of the 381 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [190]Berk M Dean OM Cotton SM Jeavons S Tanious M Kohlmann K. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry. (2014) 75: 628– 36. 10.4088/JCP.13m08454 25004186 · DOI · Paper page

Cited by

Sorted by citations

Authors
Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M.
Affiliations
  • Barwon Health (AU)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
  • Centre for Addiction and Mental Health (CA)
  • The University of Texas Health Science Center at Houston (US)
Corresponding author
Berk, Michael
Venue
Frontiers in Psychiatry
Published
2021-07-06
Volume
12
Pages
546801-546801
ISSN
1664-0640 (ISSN-L)
OpenAlex
W3182426097
Cited by
140
References
381
Citations by year
2026: 21 · 2025: 28 · 2024: 33 · 2023: 36 · 2022: 21 · 2021: 1
FWCI
2.98
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders
  • John S. Dunn Foundation
  • Centres de Recerca de Catalunya
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Generalitat de Catalunya (2017 SGR 1365, SLT006/17/00357, 2017-SGR, PI18/ 00805)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Ministerio de Ciencia e Innovación (PI15/00283, PI18/00805, PI15/00283,PI18/00805, PI19/00394, PI18/01001, PI15/, CPII19/00009, SLT006/17/00357, 2017 SGR 1365)
  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
  • Centro de Investigación Biomédica en Red de Salud Mental (SLT006/17/00357, 2017 SGR 1365)
  • Instituto Mente e Cérebro - Neurociência
  • National Health and Medical Research Council (1059660 and 1156072, 1156072, 1059660)
  • Instituto de Salud Carlos III (PI15/00283, (CPII19/00009), 2017 SGR 1365, PI18/01001, PI18/00805, PI19/00394, SLT006/17/00357)
  • European Regional Development Fund (PI19/00394, SLT006/17/00357, CPII19/00009)
  • National Institute of Mental Health (R21MH117636, 1059660, 1156072)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
mitochondria, mitochondrial dysfunction, mood disorders, major depressive disorder, bipolar disorder, oxidative stress, energy metabolism, antioxidant therapy, adjuvant therapy, treatment-resistant depression, mitochondrial-targeted therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review